CYTEK BIOSCIENCES, INC. Increase (Decrease) in Inventories
CYTEK BIOSCIENCES, INC. (CTKB) reported Increase (Decrease) in Inventories of $4.49 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was $2.86M, a 19.92% decline year-over-year.
- CYTEK BIOSCIENCES, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was $1.63M, a 8.25% increase year-over-year.
- CYTEK BIOSCIENCES, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$2.05M.
- CYTEK BIOSCIENCES, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was $2.22M.
- CYTEK BIOSCIENCES, INC. increase (decrease) in inventories for fiscal 2025 was $5.24M.
- CYTEK BIOSCIENCES, INC. increase (decrease) in inventories for fiscal 2024 was -$14.76M.
- CYTEK BIOSCIENCES, INC. increase (decrease) in inventories for fiscal 2023 was -$4.29M, a 124.28% decline from fiscal 2022.
- CYTEK BIOSCIENCES, INC. increase (decrease) in inventories for fiscal 2022 was $17.65M, a 149.76% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $4.49M 10-Q · filed 2026-08-05 | $2.44M derived: sum of 3 quarters · filed 2026-08-05 | $4.66M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.63M 10-Q · filed 2026-05-07 | -$424.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.80M derived: sum of 3 quarters · filed 2026-05-07 | $5.37M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $171.00K derived: sum of 2 quarters · filed 2026-02-26 | $3.74M derived: sum of 3 quarters · filed 2026-08-05 | $5.24M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $5.79M derived: sum of 2 quarters · filed 2026-08-05 | $7.29M 10-Q · filed 2025-11-05 | $5.29M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $3.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.07M 10-Q · filed 2026-08-05 | $3.07M derived: sum of 3 quarters · filed 2026-08-05 | -$483.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.50M 10-Q · filed 2026-05-07 | -$497.00K derived: sum of 2 quarters · filed 2026-05-07 | -$4.05M derived: sum of 3 quarters · filed 2026-05-07 | -$8.48M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$5.56M derived: sum of 2 quarters · filed 2026-02-26 | -$9.98M derived: sum of 3 quarters · filed 2026-02-26 | -$14.76M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$3.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$7.98M derived: sum of 2 quarters · filed 2025-11-05 | -$12.76M 10-Q · filed 2025-11-05 | -$19.09M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$4.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$9.20M 10-Q · filed 2025-08-06 | -$15.53M derived: sum of 3 quarters · filed 2026-02-26 | -$13.64M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$4.77M 10-Q · filed 2025-05-08 | -$11.11M derived: sum of 2 quarters · filed 2026-02-26 | -$9.22M derived: sum of 3 quarters · filed 2026-02-26 | -$12.25M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$6.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$4.45M derived: sum of 2 quarters · filed 2026-02-26 | -$7.47M derived: sum of 3 quarters · filed 2026-02-26 | -$4.29M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.14M derived: sum of 2 quarters · filed 2024-11-07 | $2.05M 10-Q · filed 2024-11-07 | $163.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$3.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $159.00K 10-Q · filed 2024-08-06 | -$1.73M derived: sum of 3 quarters · filed 2025-02-28 | $3.46M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $3.19M 10-Q · filed 2024-05-08 | $1.30M derived: sum of 2 quarters · filed 2025-02-28 | $6.49M derived: sum of 3 quarters · filed 2025-02-28 | $14.92M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $3.30M derived: sum of 2 quarters · filed 2025-02-28 | $11.73M derived: sum of 3 quarters · filed 2025-02-28 | $17.65M 10-K · filed 2025-02-28 |
| 2022-09-30 | $5.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $13.62M derived: sum of 2 quarters · filed 2023-11-14 | $19.54M 10-Q · filed 2023-11-14 | $21.77M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-06-30 | $8.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $14.36M 10-Q · filed 2023-08-08 | $16.59M derived: sum of 3 quarters · filed 2024-03-13 | $17.55M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-03-31 | $5.92M 10-Q · filed 2023-05-09 | $8.15M derived: sum of 2 quarters · filed 2024-03-13 | $9.12M derived: sum of 3 quarters · filed 2024-03-13 | $9.38M derived: sum of 4 quarters · filed 2024-03-13 |
| 2021-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $3.19M derived: sum of 2 quarters · filed 2024-03-13 | $3.45M derived: sum of 3 quarters · filed 2024-03-13 | $7.07M 10-K · filed 2024-03-13 |
| 2021-09-30 | $964.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.22M derived: sum of 2 quarters · filed 2022-11-09 | $4.84M 10-Q · filed 2022-11-09 | $5.12M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $260.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $3.87M 10-Q · filed 2022-08-10 | $4.16M derived: sum of 3 quarters · filed 2023-03-01 | $5.09M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $3.61M 10-Q · filed 2022-05-12 | $3.90M derived: sum of 2 quarters · filed 2023-03-01 | $4.83M derived: sum of 3 quarters · filed 2023-03-01 | |
| 2020-12-31 | $283.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.22M derived: sum of 2 quarters · filed 2023-03-01 | $5.70M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $935.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $5.42M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $4.49M 10-Q · filed 2021-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |